Cart
sales@molnova.com
Home - Products - Others - Other Targets - SEC inhibitor KL-1

SEC inhibitor KL-1

CAS No. 900308-84-1

SEC inhibitor KL-1( KL-1 )

Catalog No. M24926 CAS No. 900308-84-1

SEC inhibitor KL-1 exhibits a dose-dependent inhibitory effect on AFF4-CCNT1 interaction (Ki: 3.48 μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 87 In Stock
2MG 48 In Stock
5MG 79 In Stock
10MG 126 In Stock
25MG 216 In Stock
50MG 319 In Stock
100MG 454 In Stock
200MG 631 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    SEC inhibitor KL-1
  • Note
    Research use only, not for human use.
  • Brief Description
    SEC inhibitor KL-1 exhibits a dose-dependent inhibitory effect on AFF4-CCNT1 interaction (Ki: 3.48 μM).
  • Description
    SEC inhibitor KL-1 exhibits a dose-dependent inhibitory effect on AFF4-CCNT1 interaction (Ki: 3.48 μM). SEC inhibitor KL-1 is a potent, selective super elongation complex (SEC) inhibitor and disrupts the interaction between the SEC scaffolding protein AFF4.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    KL-1
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    SEC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    900308-84-1
  • Formula Weight
    345.78
  • Molecular Formula
    C18H16ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (120.51 mM; Need ultrasonic)
  • SMILES
    CC1=C(C=C(C=C1)Cl)NC(=O)C(=O)CC(=O)C2=CC(=CC=C2)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Liang K, et al. Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced CancerTherapy. Cell. 2018 Oct 18;175(3):766-779.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • GSK-25

    GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).

  • GSK2033

    GSK2033 is an antagonist of LXR (pIC50s: 7 and 7.4 for LXRα or LXRβ, respectively).

  • C12-200

    C12-200 is a benchmark ionizable cationic lipidoid along with helper lipids. C12-200 is commonly used for mRNA delivery.

Sign In Join Free